Up a level |
Smith, Eve MD, Gorst, Sarah L ORCID: 0000-0002-7818-9646, Al-Abadi, Eslam, Hawley, Daniel P, Leone, Valentina, Pilkington, Clarissa, Ramanan, Athimalaipet V, Rangaraj, Satyapal, Sridhar, Arani, Beresford, Michael W ORCID: 0000-0002-5400-9911 et al (show 1 more authors)
(2021)
“It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE.
Rheumatology, 60 (12).
pp. 5630-5641.
Smith, Eve MD, Rasul, Sajida, Ciurtin, Coziana, Al-Abadi, Eslam, Armon, Kate, Bailey, Kathryn, Brennan, Mary, Gardner-Medwin, Janet, Haslam, Kirsty, Hawley, Daniel P et al (show 17 more authors)
(2021)
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study.
RHEUMATOLOGY, 60 (11).
pp. 5271-5281.
Charras, Amandine, Haldenby, Sam, Smith, Eve MD, Egbivwie, Naomi, Olohan, Lisa, Kenny, John G, Schwarz, Klaus, Roberts, Carla, Al-Abadi, Eslam, Armon, Kate et al (show 16 more authors)
(2023)
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE.
RHEUMATOLOGY, 62 (SI2).
SI210-SI225.
Smith, Eve MD, Egbivwie, Naomi, Jorgensen, Andrea L ORCID: 0000-0002-6977-9337, Ciurtin, Coziana, Al-Abadi, Eslam, Armon, Kate, Bailey, Kathryn, Brennan, Mary, Gardner-Medwin, Janet, Haslam, Kirsty et al (show 16 more authors)
(2022)
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study.
CLINICAL IMMUNOLOGY, 239.
109028-.